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Summary
γδ T cells contribute uniquely to host immune competence, but how they do so remain unclear. Here,
by analyzing T10/T22-specific γδ T cells in mice with different T10/T22 expression patterns, we
find that encountering antigen in the thymus is neither required nor inhibitory for the development
of these cells. Instead, ligand recognition determines which of two distinct functional subsets γδ T
cells will become. When triggered through the TCR, lymphoid-γδ T cells that encounter ligand during
development produce IFNγ, while those that develop in the absence of ligand make IL-17, a major
inducer of granulopoiesis during inflammation. Indeed, we find large fractions of IL-17+ γδ T cells
from the draining lymph nodes immediately after peptide/CFA immunization and days before the
appearance of antigen specific IL-17+ αβ T cells. This suggests a critical role for γδ T cells as ‘initial
providers’ of IL-17 in an inflammatory response to novel antigens.
Introduction
γδ T cells and αβ T cells are present together in all but the most primitive vertebrates. In most
adult animals, αβ T cells are the predominant T-cell population and also perform many of the
well-defined functions attributed to T cells. Nevertheless, in experimental systems where αβ
T cell and/or γδ T cell deficient mice are infected with pathogens, the absence of both T-
lymphocyte populations generally results in a more severe infection. In particular, γδ T cell-
deficient mice usually fare worse in neutrophil-dominated inflammatory responses, heat-,
ozone- or chlorine-induced injuries and in bacterial infections (Nocardia asteroids, Klebsiella
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pneumonia) (King et al., 1999; Koohsari et al., 2007; Moore et al., 2000; Toth et al., 2004). In
these cases, fewer infiltrating neutrophils, increased bacterial load, early dissemination and
higher mortality rates are noted. Furthermore, patients with bacterial, parasitic and viral
infections often have increased numbers of γδ T cells in the peripheral blood (from <5% in
healthy individuals to >45% in patients) (De Paoli et al., 1990; Ho et al., 1990; Jason et al.,
2000). It was also reported that γδ T cells are over-represented among infiltrating T cells in the
early but not in the late lesions of MS patients (up to 20-30% of the total number of T cells)
(Wucherpfennig et al., 1992). These observations suggest that γδ T cells play a unique role in
the initial host response to tissue damage and infection. However, it is unclear why and how
γδ T cells are preferentially suited for this task.
γδ T cells, like αβ T cells, develop in the thymus before entering the periphery. In the case of
αβ T cells, thymic development entails ligand driven positive and negative selection, which
determine what αβ T cell can recognize (Huseby et al., 2005; Van Laethem et al., 2007); and
whether these T cells will develop into CD4+ helper or CD8+ cytolytic T cells. Thus,
understanding γδ T cell selection in the thymus could provide valuable clues as to their likely
targets and function.
Previous analysis of the role of thymic selection in the establishment of a functional γδ T cell
repertoire has focused mostly on the studies of KN6 and G8 γδ TCR transgenic mice. KN6 and
G8 are two independently derived γδ T cell clones that recognize the same closely related,
β2m-associated non-classical MHC class I molecules, T10 and T22 (Ito et al., 1990; Schild et
al., 1994; Weintraub et al., 1994). In both systems, transgenic mice were crossed to the C57BL/
6 (B6) background, which express both the inducible T10 and constitutively expressed T22;
BALB/c mice which only express T10, or to the β2m-/- background which do not have cell
surface T10/T22 expression. It was reported that in C57BL/6 mice, there were significantly
lower numbers of or no transgenic T cells in the spleens of BALB/c mice. There were also
fewer G8 γδ thymocytes (Dent et al., 1990). While KN6 thymocytes were present, their ability
to secrete IL-2/IL-4 and to proliferate was much reduced (Bonneville et al., 1990). When G8
and KN6 transgenic T cells were expressed in β2m-/- mice (B6 background), there were fewer
transgenic cells in the periphery and transgenic thymocytes showed a reduced ability to secrete
cytokine and proliferate when stimulated in vitro (Pereira et al., 1992; Wells et al., 1991). Based
on these observations, it was concluded γδ T cells, similar to αβ T cells, undergo ligand driven
positive and negative selection in the thymus. However, analyzing the same G8 transgenic
mice, Schweighoffer and Fowlkes found that G8 T cells were able to mature in β2m-/- mice,
contradicting the conclusion that positive selection is required (Schweighoffer and Fowlkes,
1996).
In addition to the KN6 and G8 transgenic systems, the role of ligand recognition in the
development of murine skin-dendritic epidermal T cells (DETCs) has also been analyzed.
These γδ T cells express the same TCR and are the first to appear during fetal thymic
development (Havran and Allison, 1988). While the ligand of these cells has yet to be identified,
DETCs are reactive to keratinocytes in a TCR dependent manner (Havran et al., 1991). Here,
all experimental results suggest that encountering thymic ligand is necessary for DETCs to
migrate to the skin and to acquire their ability to react to keratinocytes (Lewis et al., 2006;
Mallick-Wood et al., 1998; Xiong et al., 2004).
Previously, we found that a sizable population (0.1-1%) of γδ T cells in normal un-immunized
mice recognize T10/T22 (Crowley et al., 2000). Surprisingly, a comparable frequency of T10/
T22-specific γδ T cells was also found in β2m-/- mice (Crowley, 1998). Moreover, in analyzing
the antigen recognition determinant of T10/T22-specific γδ T cells, we found that the T10/T22
specificity is largely encoded by amino acid residues on Vδ and Dδ gene elements which are
brought together by rearrangement; and that 0.85% of the non-selected TCRδ sequences (from
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CD3ε-deficient murine thymocytes and from out-of-frame VDJ recombination events) contain
the T10/T22 recognition motif (Shin et al., 2005). This is within the observed range of T10/
T22-specific γδ T cells in normal mice. Therefore, this repertoire seems to be determined
largely by gene rearrangement instead of ligand dependent selection-observations, which
present a significant departure from the analysis of T10/T22-specific γδ TCR transgenic mice.
If γδ T cells require no ligand driven positive or negative selection to develop, then the
repertoire of γδ T cell antigens will be significantly enlarged to include pathogens, which do
no cross-react to host thymic molecules, as well as infection- or stress-induced antigens which
express in the thymus, such as T10/T22. Furthermore, although γδ T cells and αβ T cells secrete
similar cytokines and mount cytolytic responses, there is very little information on how γδ T
cell effector functions develop. Since we have developed a T22 tetrameric staining reagent
(Crowley et al., 2000), which allows us to follow and analyze this substantial population of
T10/T22-specific γδ T cells in normal non-transgenic mice, we decided to re-evaluate these
issues.
Here, we find that (1) encountering antigen in the thymus is neither required nor inhibitory for
the development of T10/T22-specific γδ T cells, (2) self-dimerization of γδ TCRs may be
sufficient to drive γδ thymocytes development, (3) a sizable number of the γδ T cells in normal
mice are phenotypically and functionally similar to β2m-/- T10/T22-specific cells, suggesting
that most γδ T cells in the periphery have yet to encounter antigen, and (4) when activated
through the TCR, cells with prior antigen exposure produce IFNγ, while cells that develop in
the absence of ligand make IL-17, a major initiator of inflammation and that is elicited without
prior antigen. Indeed, we find that γδ T cells are major IL-17 producers in the draining lymph
nodes after peptide/Complete Freund’s Adjuvant (CFA) immunization. These results suggest
that a functional γδ T repertoire can be divided into two subsets, influenced by ligand
recognition, and uniquely equipped to initiate and regulate the inflammatory response.
Results
The presence of T10/T22-specific γδ T cells is neither inhibited nor enhanced by host T10/
T22 expression
To determine the role of ligand recognition in the development of a functional γδ T cell
repertoire, we first analyzed the frequency of T10/T22-specific γδ T cells in C57BL/6, BALB/
c, and β2m-/- mice using a fluorescently labeled T22 tetramer. T10/T22-specific γδ T cells
were found within a similar range (0.1-1% of the total γδ T cell population) in the thymuses,
spleens and the inter-epithelial lymphocyte (IEL) compartments of all three strains of mice
(Fig. 1A, and data not shown). Regardless of the genetic background of the mice, T10/T22-
specific γδ T cells also show a spectrum of affinity to T22 as evaluated by tetramer staining
intensity (Fig. 1B). They express TCRs that are diverse in V gene usage and CDR3 junctional
sequences but with the same (W-SEGYEL) recognition motif in the TCRδ CDR3 (data not
shown) as previously described for T10/T22-specific γδ T cells from B10.BR mice (Shin et
al., 2005). These results show that endogenous ligand expression does little to influence the
number, TCR usage and the recognition motif of T10/T22-specific γδ T cells.
A similar frequency of T10/T22-specific cells was observed in the thymuses and spleens of
mice lacking both β2m and class II MHC molecules, whether or not they were treated with
cyclosporin A (to inhibit αβ T cell positive selection) (data not shown). These results show
that the development of the T10/T22-specific γδ repertoire is neither inhibited by nor dependent
on the expression of T10/T22, of class II MHC or any other β2m-associated molecules, nor
does it require signaling pathways utilized for αβ T cell positive selection. Thus, the
development of T10/T22-specific γδ T cells does not require either positive or negative
selection, as described for the development of αβ T cells.
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Encountering T10/T22 is not necessary for T10/T22-specific γδ thymocytes to signal through
the TCR or to exit from the thymus
The maturation of γδ thymocytes requires signalling through the TCR (Haks et al., 2005; Hayes
et al., 2005). T10/T22-specific γδ thymocytes from different ligand expressing environments
show similarly high levels of phosphorylated ERK1/2 (pERK1/2) (Fig. 2A), a TCR signaling
intermediate in the MAP kinase pathway, and of CD5 (Fig. 2B), a stable indicator of signaling
strength (Azzam et al., 1998; Tarakhovsky et al., 1995). In fact, the pERK1/2 levels in B6 and
β2m-/- γδ thymocytes, regardless of their T10/T22 specificities are higher than those from
CD4+CD8+ and CD4+CD8- αβ thymocytes (Fig. 2A, S1). Although it was reported that in the
absence of ligand, KN6 TCR transgenic γδ T cells adopt an αβ T cell fate as defined by CD4/
CD8 expression and lowered γδ TCR levels (Haks et al., 2005), we find that tetramer positive
γδ T cells in β2m-/- mice remain CD4-CD8-(Fig. 2C) and show no TCR down-regulation (Fig.
1C). In this regard, although a >20-fold increase in CD4+8+ KN6+ T cells was reported in the
thymuses of KN6 β2m-/- RAG-/- mice, there was also a two-fold increase in the number of
CD4-8-transgenic T cells (Haks et al., 2005). Thus, the expansion of the double positive cells
may not have been at the expense of the γδ lineage cells in that setting.
Up-regulation of sphingosine-1-phosphate receptor 1 (S1P1) is necessary for mature
thymocytes to exit the thymus (Matloubian et al., 2004), and we find no observable difference
in the high S1P1 expression between tetramer-positive and tetramer-negative thymocytes from
B6 and β2m-/- mice (Fig. 2D). Taken together, these results indicate that endogenous thymic
ligand expression does very little to constrain γδ thymocyte development, thymic exit and
maturation. These aspects represent a significant departure from what has been known for
αβ T cell development and what has been thought previously about γδ T cell selection.
TCR dimerization provides a possible ligand independent mechanism for signaling through
the TCR
In αβ thymocyte development, autonomous signaling mediated by the dimerization of the pre-
Tα has been suggested for pre- T cell activation (Yamasaki et al., 2006). Interestingly, the
crystal structure of the G8 γδ TCR with its T22 ligand showed a dimerized complex between
the TCR Vδ domains (Adams et al., 2005). We therefore tested whether or not γδ TCRs can
dimerize to induce signaling without cross-linking by ligand. The extracellular domain of the
human erythropoietin receptor (EPOR) gene was replaced with the TCRδ chain extracellular
domain and expressed together with the extracellular domain of the TCRγ chain in BaF3 cells
(Fig. 3A). EPOR signaling mediated through dimerization of the extracellular domain allows
these cells to grow in the absence of IL-3 (Yoshimura et al., 1990). We found that all of the
Vγ/Vδ-EPOR fusion protein pairs, except for Vγ5/Vδ1-EPOR, were able to promote the growth
of BaF3 cells after IL-3 withdrawal (Fig. 3B, and Fig. S2). The Vδ1/Vγ5 TCR we tested here
is from the DETCs, which constitute the first wave of T cells that appear during fetal thymic
development and later populate the murine skin. Various reports suggest that these cells require
antigen-driven positive selection for development (Lewis et al., 2006; Mallick-Wood et al.,
1998; Xiong et al., 2004). Thus, our results offer a possible ligand-independent mechanism for
signaling through the γδ TCR (with the exception of the DETC TCR), which may be sufficient
to drive the development of γδ thymocytes, which have high pERK1/2 levels (Fig. S1). In this
context, Prinz et al. analyzed the development of γδ thymocytes and suggested that surface
expression of γδ TCR on thymocytes is the only “check point” in the development which
involves a phase of proliferation with magnitude similar to that induced by Pre-Ta (Prinz et
al., 2006).
A large fraction of lymphoid γδ T cells exhibit an ‘antigen-naïve’ phenotype
While T10/T22-specific thymocytes in B6, BALB/c, and β2m-/- mice are similar in number
and have comparable tetramer staining intensities, their phenotypes suggest that majority from
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B6 and BALB/c mice encounter antigen and those from β2m-/- mice do not. In particular, T10/
T22-specific cells from B6 and BALB/c mice express lower levels of TCR (Fig. 1C) and heat
stable antigen (HSA, or J11D), but higher levels of the IL-2/IL-15 receptor common β chain
(CD122) than those from β2m-/- mice (Fig. 1D, E). αβ Thymocytes that have encountered
ligand express lower levels of HSA, and a HSAlo profile has also been reported for G8 γδ TCR
transgenic thymocytes that develop in the presence of ligand (Schweighoffer and Fowlkes,
1996;Wells et al., 1991). Furthermore, the upregulation of CD122 has been used as an indicator
of self-ligand recognition in αβ thymocytes (Hanke et al., 1994) and during murine skin γδ
dendritic epidermal cells (DETCs) development (Xiong et al., 2004).
Keeping with the idea that exposure to ligand is not necessary for γδ T cells to exit from the
thymus, T10/T22-specific γδ splenocytes from β2m-/- mice exhibit the phenotype of T cells
which have not encountered antigen. Specifically, the majority of these cells are CD44lo,int and
CD122lo,int while splenocytes from B6 mice are CD44hi, CD122hi, and a greater fraction of
these cells are DX5+, NK1.1+, and CD5lo (Fig. 1F). In addition, there are consistently lower
numbers of γδ splenocytes with very high tetramer staining in B6 mice than in β2m-/- mice
(Fig. 1B) suggesting that cells with TCRs possessing very high affinity to T10/T22 have been
deleted in B6 mice. Since the G8 TCR has the highest affinity to T10/T22 among all the T10/
T22 specific receptor pairs that we have analyzed (Shin et al., 2005) (and data not shown), it
is not surprising that G8 transgenic T cells were not found in the spleen of B6 mice (Dent et
al., 1990).
Significantly, the surface marker expression pattern of tetramer-negative γδ thymocytes and
splenocytes (i.e. >99% of the total γδ T cell population) in all strains of mice is more similar
to that of T10/T22-specific γδ T cells from β2m-/- mice, than to those from B6 and BALB/c
mice (Fig. 1D-F), suggesting that a significant fraction of γδ cells may not have encountered
ligand during their development or in the periphery.
It has been reported that peripheral CD44hi γδ T cells have a higher turnover rate than their
CD44lo-int counterparts (Tough and Sprent, 1998), and IL-15 has been observed to enhance
homeostatic proliferation of γδ T cells in lymphopenic animals (Baccala et al., 2005; French
et al., 2005). Since T10/T22-specific γδ T cells that develop in B6 and BALB/c mice generally
express higher levels of CD122 and CD44 than the rest of γδ T cells, we asked whether these
cells have enhanced turnover rates in vivo and if this would lead to a ligand driven bias in the
repertoire. To test this, we measured the amount of BrdU incorporation in tetramer-positive
and tetramer-negative γδ splenocytes from different strains of mice.
As shown in Fig. 4, T10/T22-specific γδ T cells from B6 and BALB/c mice incorporated
significantly more BrdU after 7-day labeling than the vast majority of γδ T cells. However,
this difference is no longer apparent after a 28-day chase preceded by 24-day labeling. Thus,
encountering antigen increases the turnover of T10/T22-specific γδ T cells, but does not ‘fix’
this specificity in the repertoire. Indeed, we found no significant differences in the frequency
of tetramer-positive cells from any strain of mice between two, seven, twelve, fourteen and
twenty weeks of age (data not shown).
Importantly, tetramer-positive and tetramer-negative γδ T cells from β2m-/- mice had similar
levels of BrdU incorporation across all experimental conditions, indicating that, lack of ligand
recognition during development and in the periphery does not compromise the turn-over ability
of antigen specific γδ T cells. In addition, the turnover rate of the majority of the splenic γδ T
cells are similar to that of T10/T22-specific γδ T cells which develop in β2m-/- mice, further
supporting the notion that a significant number of peripheral γδ T cells have yet to encounter
antigen.
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Antigen recognition during development defines γδ T cell functional subsets
To test whether encountering ligand during development affects the ability of γδ T cells to
make cytokines, we first analyzed YETI mice (B6 background), which express an IFNγ-YFP
bicistronic reporter (Stetson et al., 2003). This allowed us to evaluate IFNγ expression using
FACS analysis for YFP, as γδ T cells are known to make this cytokine (Ferrick et al., 1995).
We found that T10/T22-specific γδ splenocytes in YETI mice are mostly YFP+, indicating that
developing in the presence of antigen, does not compromise their ability to make IFNγ.
Consistent with this supposition, most of the CD122hi YETI splenocytes are also YFP positive
(Fig. 5A). In addition, CD122hi γδ splenocytes from B6 mice stimulated with plate-bound
TCRδ cross-linking antibody GL-4 secrete high levels of IFNγ (Fig. 5B). In contrast, the
majority of the CD122lo γδ splenocytes from YETI mice do not express YFP (Fig. 5A), and
CD122lo B6 γδ splenocytes make very little or no IFNγ upon stimulation (Fig. 5B). Instead,
we found that freshly isolated CD122lo γδ splenocytes respond to GL-4 stimulation by secreting
high levels of IL-17. Thus, naïve γδ cells respond to TCR triggering readily. This is in stark
contrast to the activation requirements of αβ T cells, which require an initial antigen specific
priming event by professional antigen presenting cells before developing into effectors cells
with the capability to secrete cytokines.
To test whether the ability of γδ T cells to respond is acquired in the thymus, we first analyzed
γδ thymocytes in YETI mice. As shown in Fig. 5, ∼20% of CD122hi cells and a similar
percentage of the T10/T22-specific thymocytes in YETI mice are YFP+. In contrast, most of
the CD122lo γδ thymocytes in YETI mice are YFP-. As in the spleen, CD122hi γδ thymocytes
make IFNγ and only CD122lo cells make high levels of IL-17 after GL-4 stimulation (Fig. 5C).
Taken together, these results indicate that γδ T cells can acquire their effector functions in the
thymus.
In B6 and BALB/c mice, T10/T22-specific γδ hymocytes show a range of CD122 expression
(Fig. 1D), which may reflect the heterogeneity in TCR-ligand binding affinities, Vδ gene usage
(which have different dimerization potentials), developmental stages of these cells and/or IL-2,
IL-15 signalling. However, most of the T10/T22-specific γδ T cells in the spleen of B6 mice
are CD122hi (Fig. 1D), and in the lymph nodes, CD122lo (Fig. 1G). In fact, most of the γδ
splenocytes express higher levels of CD122 than lymph node γδ T cells do (Fig. 1G, 1F).
Although the mechanism leading to this biased distribution is unclear, it appears that αβ T cells
also show similar differential ‘sorting’, where memory αβ T cells (that have encountered
antigens previously), are preferentially found in the spleen than in the lymph nodes (Forster et
al., 1999). Similar to γδ hymocytes and splenocytes, CD122lo lymph node γδ T cells respond
to TCR cross-linking by preferentially making IL-17 (Fig. 5C). Our results here indicate that
T10/T22-specific γδ T cells in the spleen and the thymus of B6 and β2m-/- mice will mount
different cytokine responses. This difference may explain in part the perceived requirement
for ligand-driven positive selection during the development of G8 and KN6 transgenic γδ T
cells, where cytokines IL-2/4 was used as a readout for thymocyte maturation (Pereira et al.,
1992;Wells et al., 1993).
While lymphoid γδ T cells are CD122lo and make IL-17, this is not the case for γδ IELs, which
are noted for being cytolytic directly ex vivo in re-directed lysis assays (Lefrancois and
Goodman, 1989). Regardless of antigen specificity and the host’s genetic background, these
cells are uniformly CD122lo but constitutively express high levels of Eomes, Granzyme A, B
(Fahrer et al., 2001; Shires et al., 2001)(data not shown). In this context, it should be noted that
γδ IELs are not only very different than lymphoid γδ T cells in gene expression but also in their
development, maturation, and survival requirement (Hayes and Love, 2007).
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IL-17 producing γδ T cells appear early after peptide/CFA immunization
IL-17 regulates the expansion and recruitment of neutrophils and monocytes to initiate the
inflammatory response (Ley et al., 2006; Stark et al., 2005). In an acute inflammatory response,
a swift IL-17 response must be elicited without prior antigen exposure, suggesting that γδ T
cells may be uniquely suited to produce IL-17 at the onset of the inflammatory response. To
test this directly, we immunized B6 mice with myelin oligodendrocyte glycoprotein (MOG)
peptide (35-55), in Complete Freund’s Adjuvant (CFA), as a surrogate to induce acute
inflammation, and to prime antigen specific αβ T cells. T cells were isolated from the draining
lymph nodes and stimulated with anti-CD3 for 24 hours in vitro before intracellular IL-17
staining. As shown in Figure 6, although the MOG-specific, as well as a significant CD4+
αβ T cell IL-17 response is not observed until day 3 or 4, a large fraction of lymph node γδ T
cells from B6 mice produce IL-17 before and immediate after immunization. These include
T10/T22-specific γδ T cells from B6 as well as from β2m-/- mice (Fig. 6E), demonstrating that
encountering ligand during development is neither required nor inhibitory for γδ T cell to
respond by producing cytokine.
In vertebrates, antigen specific αβ T cell responses are initiated by the inflammatory response.
In this context, we have confirmed an earlier report by Weiner and colleagues (Spahn et al.,
1999) that that experimental autoimmune encephalomyelitis (EAE) can be induced readily by
MOG/CFA immunization in C57BL/6 mice, but with a delayed onset and much-reduced
severity in TCRδ-/- mice on the same genetic background (Fig. 6D). This disease model has
been used extensively in the evaluation of the development of Th17 αβ T cells (Bettelli et al.,
2007).
Discussion
In the data presented here we show that a population of antigen specific γδ T cells is neither
positively nor negatively selected in the thymus. This is in contrast to some (but not all
(Schweighoffer and Fowlkes, 1996)) of the previous findings using mice expressing transgenic
TCRs with the same specificity. These differences may also be due to the tendency of
endogenous pre-rearranged TCR genes to skew T lymphocyte development (Serwold et al.,
2007). While the development of dendritic epidermal T cells (DETCs) seem to require ligand
driven positive selection, these cells are derived from the very first wave of γδ T cells during
fetal thymic development and are unusual in that they have a largely monomorphic TCR and
reside only in the skin of mice. Thus, it is arguable that the T10/T22-specific γδ T cells studied
here are more typical of γδ T cells in adult mice.
Our results also showed that Vδ’s can self-dimerize as assayed with chimeric EPOR molecules
in BAF3 cells. We suggest that this mechanism may allow γδ T cells to signal and mature in
the thymus in the absence of a TCR ligand. TCR dimerization may also enhance antigen
specific activation of peripheral γδ T cells, which are known to signal more efficiently than
αβ T cells (Hayes et al., 2003) despite lacking CD4/CD8 co-receptor expression and having
low levels of pERK1/2 similar to those of naïve αβ T cells (Fig. S2B). These are testable
hypothesis and we are actively pursuing them.
Surprisingly, while ligand expression does little to constrain antigen specificities of the γδ T
cell repertoire, it does play a role in endowing lymphoid γδ T cells with different functional
programs. We find very clear evidence for two distinct functional subsets of lymphoid γδ T
cells, namely ligand naïve cells which can make IL-17, designated as Tγδ-17s, and ligand
experienced cells which secrete Interferon γ, designated Tγδ-IFNγ. While a significant
population of splenic γδ T cells are Tγδ-IFNγ, the majority of the lymph node γδ cells, are
Tγδ-17s. This is particularly significant as lymph nodes serves largely as the initial collection
point of foreign antigens and a site for propagating inflammation. We are currently
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investigating whether the functional programs determined by ligand recognition can be
‘overwritten’ by tissue specific environments, and whether there is functional plasticity in these
types of cells.
It is of particular importance that regardless of ligand experience, γδ T cells are able to make
cytokines immediately upon TCR engagement. In higher vertebrates, IL-17 is made early in
the host response to tissue damage or infection, leading to neutrophil maturation and their
recruitment from the bone marrow (Stark et al., 2005). The major source of IL-17 is from T
lymphocytes. Yet, it has been unclear how the early stages of the IL-17 response could be
elicited from the classic antigen-specific αβ Th17 cells, which can take 4 to 7 days to develop,
and requires both antigen-specific priming, co-stimulation provided by professional antigen
presenting cells and a particular cytokine environment (Weaver et al., 2006). Thus, the new
subset of γδ T cells that we describe here is ideally suited to provide IL-17 in the very earliest
stages of an inflammatory response, before antigen specific αβ T cells are able to. This may
explain reports showing that γδ T cells are particularly important in neutrophil dominated
infectious diseases such as- Mycobacterium tuberculosis (Lockhart et al., 2006), Nocardia
asteroides (Umemura et al., 2007), Escherichia coli (Shibata et al., 2007) and pulmonary
aspergillosis in chronic granulomatous disease (CGD) (Romani et al., 2008), and in a mouse
model of autoimmunity (Roark et al., 2007).
The influx of neutrophils sets in motion the recruitment of other leukocytes at the site of
inflammation, which in turn affects the local cytokine milieu and subsequent antigen specific
B and T cell responses. Thus, γδ-17s could play a crucial role in B and αβ T cell differentiation.
Consistent with this supposition, various reports have observed deviated αβ T cell and B cell
responses in γδ T cell deficient mice (Zuany-Amorim et al., 1998), including the lack of EAE
induction as first shown by Weiner and colleagues (Spahn et al., 1999) and reproduced by us
in this work.
Cumulatively, the data points to a γδ T cell repertoire largely determined by VDJ rearrangement
and not restricted to recognize self antigens encountered during development. In addition, we
have defined two distinct subsets of lymphoid γδ T cells in mice, Tγδ-17s and Tγδ-IFNγ, which
are heavily influenced by ligand recognition. The ability of γδ T cells to produce IL-17 rapidly
without prior antigen exposure suggests that they are uniquely suited to initiate and regulate
the inflammatory response. This may be the key to understanding how they contribute to host
immune competence and why they have been maintained throughout vertebrate evolution.
Experimental procedures
Mice
6-8 week age and sex matched C57BL/6, BALB/c, β2m-/- (C57BL/6), TCR Cδ-/- (B6.129P2-
Tcrdtm1Mom/J) and β2m-/- MHC II -/- (B6.129-H2-Ab1tm1Gru B2mtm1Jae N17) mice were
purchased from either Jackson or Taconic laboratories and housed in the Stanford Animal
Facility according to guidelines set by Stanford. YETI (Yellow Enhanced Transcript for
IFNγ) mice (Stetson et al., 2003)(C57BL/6, H-2b N6) were housed at UCSF according to
guidelines set by UCSF.
Antibodies
All antibodies were purchased from eBioscience or BD Pharmingen unless otherwise stated.
FACS analysis of γδ T cells
To enrich γδ T cells, total thymocytes and splenocytes (108 cells/ml) were first incubated with
normal hamster serum, normal mouse serum (Jackson ImmunoResearch), 5 μg/ml anti-
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CD16/32 FcBlock, followed by fluorescently labeled GL-3 (anti-TCRδ) antibody and enriched
with anti-fluorescein isothiocyanate (FITC) or allophycocyanin (APC) MicroBeads (Miltenyi).
To stain GL-3 enriched γδ T cells with T22 tetramer, cells were further blocked with 4 μg/mL
CD8αCT (CALTAG) to prevent CD8-tetramer binding, followed by staining with 5-7 μg/ml
phycoerythrin (PE) labeled T22 tetramer, together with anti-CD19 Cy5PE (MB 19-1), anti-
TCRβ Cy5PE (H57), anti-KLH Armenian Hamster IgG2κ Cy5PE (GL-3 isotype) and
streptavidin Cy5PE (BD Pharmingen) for 1.5 hours on ice. After washing, cells were suspended
in FACS buffer (2% FCS PBS) with 1 μg/ml propidium iodide (PI). Six-color FACS was
performed on Vantage or LSR and data was collected using Cell Quest software. Cells positive
for PI and Cy5PE were excluded from analysis. FACS data was compensated and analyzed
using FlowJo software (Treestar).
To stain tetramer positive γδ T cells for the expression of cell surface markers, enriched and
tetramer stained γδ T cells were concurrently stained with one of the following antibodies
labeled with FITC (unless otherwise stated): anti-CD122 (TM-β1), anti-HSA (M1/69), anti-
CD127 (A7R34), anti-CD5 (53-7.3), anti-CD25 Alexa488 (3C7), anti-NK1.1 APC (NKR-
P1C), anti-CD49b (DX5), anti-CD44 (IM7), anti-CD4 APC-Cy7 (15-8-A2), anti-CD8
(CD8αCT, CALTAG), Rat IgG2aκ FITC (53-7.3 isotype), or anti-S1P1 polyclonal (UCSF)
detected with goat anti-rabbit secondary (Jackson ImmunoResearch). Tetramer positive and
negative, GL-3 positive cells were analyzed for maker expression and plotted by a histogram.
For analyzing YETI mice, TCRδ (GL-3) and CD3ε Cy7APC (145-2C11) double positive cells
were analyzed for tetramer or anti-CD122 PE staining, and YFP (IFNγ) expression.
Intracellular staining of pERK1/2 or BrdU in tetramer positive γδ T cells
To detect intracellular levels of pERK1/2 or BrdU in T22 tetramer positive cells, cell
suspensions from thymus or spleen, were blocked with serums, FcBlock and CD8αCT as
described above; stained with 15-20 μg/ml PE labeled tetramer and enriched with anti-PE
MicroBeads (Miltenyi). After enrichment, approximately 50-70% of the TCRδ+CD3ε+ cells
were tetramer positive. Tetramer enriched cells were stained with relevant antibodies, then
fixed with Cytofix/Cytoperm™ solution on ice and permeabilized with Cytoperm™/Wash
buffer (BD Pharmingen). For the detection of phosphorylated ERK1/2, cells were stained with
rabbit 197G2 (Cell Signaling) for 45 min. at room temperature. After washing, cells were
stained with anti-rabbit FITC (Jackson ImmunoResearch) for 30 min. at room temp, followed
by washing with Cytoperm™/Wash and FACS buffers. For the detection of BrdU
incorporation, samples were further permeabilized with Cytofix/Cytoperm™ Plus buffer (BD
Pharmingen) then treated with 30 μg DNase (Sigma-Aldrich) for 60 min at 37°C to expose
BrdU epitopes. After washing, cells were stained with anti-BrdU APC (3D4), for 45 min. at
room temperature followed by washing.
In vitro stimulations and the detection of IFNγ and IL-17
CD122hi and CD122lo γδ thymocytes, splenocytes and lymph node cells were FACS sorted
using a Vantage cell sorter and 105 cells/well were plated on a 96 well plate (Costar) coated
with 10 μg/ml anti-TCRδ (GL-4). Cells were cultured in RPMI 1640+GlutaMAX™-1
supplemented with 10% fetal calf serum (Hyclone), 0.1 mM non-essential amino acids
(Cellgro), 1 mM sodium pyruvate (Irvine Scientific), 100 U/ml penicillin, 100 μg/ml
streptomycin (Gibco) and 3.5 μl/L 2-mercaptoethanol (Sigma). 40 hours later supernatant was
analyzed for IFNγand IL-17 by ELISA (eBioscience).
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Construction, expression of TCR-EPOR hybrid genes in BaF3 cells and the proliferation
assays
The TCRδextracellular region (defined by an IMGT multiple sequence alignment,
http://imgt.cines.fr) was linked to the transmembrane (TM) and intracellular sequence of the
human EPOR; and the TCRγ extracellular region (defined as above) was linked to and
terminated at the end of the EPOR TM region by PCR. PCR products were TA cloned
(Invitrogen), sequenced and inserted into a pMX IRES-GFP vector(Yamasaki et al., 2006),
and transfected into ecotrophic Phoenix cells with FuGene 6 Transfection reagent (Roche)
according to manufacture’s suggestions. Viral supernatant was obtained as described
(http://www.stanford.edu/group/nolan/protocols/pro_helper_dep.html) and Vδ-EPOR/Vγ
chain pairs were used to infect BaF3 cells grown in 1 ng/ml mouse IL-3 (R & D systems).
Transfectants were FACS sorted for high (upper 10%) of GFP expression. For the proliferation
assays, sorted transfectants were washed 3 times and mixed with equal numbers of washed
parental BaF3 (GFP negative) cells, such that 105 cells/400 μl of each cell type were plated in
a 48 well plate. Various days after IL-3 removal, PI was added directly to the medium, cells
were resuspended and enumerated by FACS. The absolute number of GFP+ or GFP- (parental
BaF3) cells various days after IL-3 removal divided by the absolute number obtained on day
0 was plotted for Supplemental Figure S2. For Figure 3B, the fold growth over parental BaF3
cells on day 4 was plotted and calculated as follows: [number of chimeric EPOR transfectants
at day 4 after IL-3 removal /number of transfectants at day 0] / [number of parental BaF3 cells
at day 4 after IL-3 removal / number of parental BaF3 cells at day 4].
MOG35-55 / CFA immunization, intracellular IL-17 detection and the MOG35-55 specific IL-17
lymph node response
Mice were immunized subcutaneously with 100 μg of HPLC purified MOG35-55 peptide
(MEVGWYRSPFSRVVHLYRNGK), 200μg of heat killed mycobacterium (DIFCO)
emulsified in 1 part mineral oil and 1 part H20 (Complete Freund’s Adjuvant). Axillary,
brachial and inguinal lymph nodes were harvested at various days post immunization. Total
cell suspensions were plated at 5×106 cells per well in 48 well plates (Falcon) pre-coated with
10 μg/ml anti-CD3ε (145-2C11, no azide, low endotoxin) or Armenian Hamster IgG1κ (BD).
After incubating 24 hours at 37°C, cells were harvested, blocked with serums and FcBlock as
described above, and stained with antibodies against CD4 (GK1.5), CD8 (CD8αCT), CD3ε
(145-2C11), TCRδ (GL-3), F4/80 (BM8), CD11b (M1/70), Gr-1 (RB6-8C5), and CD19
(MB19-1). For tetramer analysis, cells were enriched with GL-3 and anti-FITC microbeads
before staining with APC labeled T22 tetramer and dump antibodies as described above. Cells
were then washed with FACS buffer, fixed and permeabilized with Cytofix™ and Cytoperm™/
Wash buffers respectively. Cells were stained with 2 μg/ml PE labeled anti-IL-17
(TC11-18H10, BD Pharmingen) or IgG1,κ isotype (R3-34, BD Pharmingen) for 30 minutes
on ice in Cytoperm™/Wash buffer. Cells were washed as described before. CD11b, Gr-1,
F4/80, CD19 positive cells were excluded from analysis. Isotype staining was used to define
cytokine positive cells.
To detect the MOG 33-55 specific IL-17 lymph node response, lymph node cells from
individual mice were isolated various days before and after peptide/CFA immunization. 106
cells were plated in a 96 well plate and incubated with various concentrations of MOG33-55
peptide in RPMI culture medium. 48 hours later supernatant was harvested and monitored for
IL-17 using anti-IL-17 beads (Bender MedSystems®) according to the manufacturer’s
protocol.
EAE was induced in C57BL/6 and TCR Cδ-/- (B6) (N=4) mice by subcutaneous immunization
with MOG peptide as described above. On the day of immunization and 2 days later, mice
were injected intravenously with 50 ng of Bordetella pertussis toxin in PBS. Mice were
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examined each day for clinical signs of EAE and scored as follows: 0, no paralysis; 1, loss of
tail tone; 2, hindlimb weakness; 3, hindlimb paralysis; 4, hindlimb and forelimb paralysis; 5,
moribund or dead.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Frequency and surface phenotypes of T10/T22-specific γδ T cells from mice with and
without T10/T22 expression
(A) Frequency; (B) tetramer staining intensity; and (C) TCR levels of T10/T22 specific γδ
thymocytes (left column) and splenocytes (right column) from C57BL/6 (B6) (T10+T22+)
(blue), C57BL/6 β2m-/- (T10-T22-) (red) and BALB/c (T10+T22-) (black) mice. Each symbol
or histogram represents the result of one mouse.
(D) Representative FACS analysis of tetramer positive (red) and tetramer negative (blue) γδ
thymocytes and splenocytes for the expression of CD122 (IL-2/IL-15R β chain) from B6,
BALB/c and β2m-/- mice.
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(E) γδ hymocytes, (F) γδ splenocytes and (E) lymph node γδ T cells from B6 and β2m-/- mice
for the expression of surface markers commonly associated with antigen recognition by T cells.
γδ T cells were first enriched with the pan-γδ antibody GL-3, followed by staining with PE
labelled T22 tetramer, antibodies to cell surface markers and Cy5PE labelled anti- CD19, anti-
TCRβ, Armenian Hamster isotype IgG2κ, streptavidin and propidium iodide (PI) as described
in Experimental Procedures. Cy5PE and PI positive cells were excluded from analysis.
Representative histogram plots are shown (n≥3).
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Figure 2. Host T10/T22 expression does not affect signalling, lineage commitment and S1P1 levels
of T10/T22-specific γδ thymocytes
Representative FACS analysis of direct ex vivo γδ thymocytes (n=3), (A) Intracellular
expression of phosphorylated ERK1/2 in tetramer+ (red), total γδ thymocytes (blue) and
CD4+8+ thymocytes (shaded).
(B) CD5 expression on tetramer+ (red) and tetramer- (blue) γδ hymocytes, isotype control on
GL-3+ γδ thymocytes (shaded).
(C) CD4 and CD8 expression on tetramer positive GL-3+ γδ thymocytes (left column), or total
thymocytes (right column) from B6 and β2m-/- mice.
(D) Sphingosine-1 Phosphate receptor-1 (S1P1) surface expression on CD4+CD8+ (black),
mature CD4+CD62Lhi αβ T cells that have gone through positive and negative selection and
ready for thymic exit (purple), GL-3+ γδ thymocytes (red) (left column); or tetramer positive
(red) and negative (blue) GL-3+ γδ thymocytes (right column) from B6 and β2m-/- mice.
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S1P1 expression was identified with a polyclonal rabbit antiserum to S1P1 (Jason Cyster,
UCSF) and detected with donkey anti-rabbit IgG FITC.
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Figure 3. TCRδ-δ interactions as assayed by the induction of BaF3 cell autonomous growth
(A) Schematic representation of TCR-EPOR chimeric genes. The TCRγ chain is fused to the
transmembrane region of the human EPOR but lacking the cytoplasmic hEPOR domain,
whereas TCRδ is fused to the transmembrane and cytoplasmic domains of the hEPOR (also
see Experimental Procedures).
(B) γδ TCR-EPOR mediated signaling allows BaF3 cell growth in the absence of IL-3. The
relative growth of TCR-EPOR expressing BaF3 cells to parental BaF3 cells day 4 after IL-3
withdraw. Ratios defined as: [number of chimeric EPOR transfectants at day 4 after IL-3
removal / number of transfectants at day 0] / [number of parental BaF3 cells at day 4 after IL-3
removal / number of parental BaF3 cells at day 4]. The survival curves of the TCR expressing
BaF3 cells are shown in supplementary Figure S2. pTα-EPOR as previously reported induces
BaF3 cell growth (Yamasaki et al., 2006) and serves as a positive control. The Vδ10/Vγ4 G8
TCR was assayed two different ways: Vδ10-EPOR/Vγ4 and Vγ4-EPOR/Vδ10. Consistent with
the crystal structure of G8 (Adams et al., 2005), the Vδ chain mediates dimerization, Vδ10-
EPOR/Vγ4 signals better than Vγ4-EPOR/Vδ10.
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Figure 4. Host T10/T22 expression enhances T10/T22-specific γδ T cell turnover but does not fix
this specificity in the repertoire
Turnover rates of tetramer positive and negative γδ splenocytes from B6, β2m-/- and BALB/
c mice. The percentage of BrdU+ cells among tetramer positive or negative γδ plenocytes were
analyzed by intracellular BrdU staining as described in Experimental Procedures after mice
were fed with 0.8 mg/ml BrdU in their drinking water for 7 days (upper panels), 24 days (middle
panels) or chased with normal drinking water for 28 days after the 24-day labeling phase (lower
panels). Each dot represents the analysis of one mouse. Data was analyzed by a paired, two-
tailed student t test.
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Figure 5. γδ T cell functional subsets
(A) γδ hymocytes (upper row) and splenocytes (lower row) from YETI (Yellow Enhanced
Transcript for IFNγ) mice (H-2b, T10+T22+) were analyzed for YFP (IFNγ) expression in
tetramer+ (red) and tetramer- (blue) cells (left column); or CD122hi (red) and CD122lo (blue)
cells right column (n=3); total γδ thymocytes or splenocytes from YFP negative littermate
controls were also analyzed (shaded). FACS analysis was performed as described in Fig. 1.
(B) IFNγ and IL-17 production by CD122hi and CD122lo γδ plenocytes, (C) γδ thymocytes
and γδ lymph node cells were FACS sorted into CD122hi and CD122lo populations according
to the indicated gate in (A), and stimulated with plate bound anti-TCRδ (GL-4) for 40 hours.
Supernatants were assayed for the production of IFNγ and IL-17 by ELISA. In (B) each symbol
represents the result of one mouse, in (C) a representative graph.
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Figure 6. IL-17+ T cells from draining lymph nodes after peptide/CFA immunization
(A) Representative intracellular IL-17 staining of γδ T cells (GL-3+CD3ε+) and; (B) Percentage
of IL-17+ cells among total γδ T cells (■) or CD4+CD8- αβ T cells (CD3ε+) (○) from the
draining lymph nodes at the indicated days after CFA/MOG35-55 immunization. Each symbol
represents the result of one mouse. Lymph node cells were isolated and stimulated with (+) or
without (-) plate bound anti-CD3ε for 24 hours followed by staining with antibodies against
CD4, CD8α, CD3ε, TCRδ, F4/80, CD11b, Gr-1 and CD19 and for intracellular IL-17 as
described in Experimental Procedures. F4/80, CD11b, Gr-1 and CD19 positive cells were
excluded from analysis.
(C) Representative dose response curves of the MOG33-55 specific IL-17 response at days 0,
3, and 4 after immunization. Lymph node cells were isolated from individual mice and
incubated with various concentrations of MOG33-55 peptide for 48 hours and assayed for IL-17
in the supernatant.
(D) Progression of EAE disease in TCR Cδ-/- and B6 mice after immunization with
MOG33-55 and pertussis toxin. The daily mean clinical score of each group is plotted (see
Experimental Procedures).
(F) IL-17 response of T10/T22-specific γδ T cells from β2m-/- or B6 mice 4 days after
MOG33-55/CFA immunization, draining lymph node cells from 12 β2m-/-, or B6 mice were
pooled and stimulated as in 6A. γδ T cells were enriched, stained with T22 tetramer and assayed
for intracellular IL-17 or stained with Rat IgG1κ isotype control (data not shown). Dot plots
display gated GL-3+ H57- CD11b- F4/80- Gr1- CD19- γδ T cells.
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